article · Dermatology
This research outlines the methodology for the Global Hidradenitis Suppurativa Atlas (GHiSA) Global Prevalence studies, which are currently underway in 58 countries across six continents. The primary objective is to generate a single, combined summary of global proportions through a proportional meta-analysis. This process involves applying a logit transformation and synthesising the data using a random-effects model. A key aspect of this work is the novel standardisation of the prevalence studies, which allows for direct international comparisons of Hidradenitis Suppurativa prevalence. This standardised approach addresses and overcomes the significant heterogeneity observed in previous HS prevalence studies, making such comparisons possible for the first time.
This standardised methodology is crucial for accurately understanding the global burden of Hidradenitis Suppurativa. By enabling direct international comparisons, it provides a clearer picture of how common the condition is worldwide, which can inform public health strategies and resource allocation.
The abstract describes a research methodology for conducting prevalence studies. It does not indicate any direct application pathway, specific user, or readiness level for commercialisation.
AI-generated from the published abstract. Always read the original work before citing.
The GHiSA Global Prevalence studies are currently running simultaneously in 58 countries across six continents (Africa, Europe, Australia, North America, South America, and Asia). The goal of the combined global proportion is the generation of a single summary (i.e., proportional meta-analysis), which will be done after a logit transformation and synthesized using a random-effects model. The novel standardization of the Global Prevalence Studies conducted through GHiSA enables direct international comparisons, which were previously not possible due to substantial heterogeneity in past HS prevalence studies.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1159/000536389
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
